DBVT Q2 2024 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$4M

Operating Income

-$35M

Net Income

-$33M

EPS (Diluted)

$-1.70

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$36M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$114M

Total Liabilities

$35M

Stockholders' Equity

$79M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2M	-100.0%
Gross Profit	-$4M	$2M	-281.5%
Operating Income	-$35M	-$25M	-39.5%
Net Income	-$33M	-$24M	-36.5%